6533b7cffe1ef96bd1258420

RESEARCH PRODUCT

Synthesis of a MUC1-glycopeptide-BSA conjugate vaccine bearing the 3'-deoxy-3'-fluoro-Thomsen-Friedenreich antigen.

Manuel JohannesAnja Hoffmann-röder

subject

digestive systemCatalysisMiceAntigenConjugate vaccineMaterials ChemistryAnimalsAntigens Tumor-Associated Carbohydrateskin and connective tissue diseasesneoplasmsMUC1Vaccines ConjugatebiologyThomsen-Friedenreich AntigenChemistryMucin-1Metals and AlloysGlycopeptidesSerum Albumin BovineGeneral ChemistryMolecular biologybiological factorsdigestive system diseasesGlycopeptideSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsCeramics and Compositesbiology.proteinCattleAntibody

description

A novel MUC1-glycopeptide–BSA conjugate vaccine with a specifically fluorinated Thomsen–Friedenreich antigen side chain at Thr6 was prepared. Preliminary immunological experiments reveal specific binding of the tumor-associated glycopeptide antigen analog by anti-MUC1-mouse antibodies.

10.1039/c1cc13184bhttps://pubmed.ncbi.nlm.nih.gov/21818465